| Company Name: |
Shenzhen Xingyue Biotechnology Co., Ltd
|
| Tel: |
18124513697; 18124513697 |
| Email: |
jjj18822823697@163.com |
| Products Intro: |
Product Name:7-Ketoabiraterone
CAS:1416316-29-4
Purity:95%+ Package:10mg/;25mg/;50mg/
|
|
| | 7-Ketoabiraterone Basic information |
| Product Name: | 7-Ketoabiraterone | | Synonyms: | 7-Ketoabiraterone;(3β)-3-Hydroxy-17-(3-pyridinyl)-androsta-5,16-dien-7-one;(3β)?-3-?Hydroxy-?17-?(3-?pyridinyl)?-androsta-?5,?16-?dien-?7-?one;Androsta-5,16-dien-7-one, 3-hydroxy-17-(3-pyridinyl)-, (3β)- | | CAS: | 1416316-29-4 | | MF: | C24H29NO2 | | MW: | 363.5 | | EINECS: | | | Product Categories: | | | Mol File: | 1416316-29-4.mol |  |
| | 7-Ketoabiraterone Chemical Properties |
| Boiling point | 545.9±50.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | solubility | soluble in Ethyl Acetate, THF | | pka | 14.31±0.70(Predicted) | | form | Solid | | color | Pale Yellow |
| | 7-Ketoabiraterone Usage And Synthesis |
| Uses | 7-Ketoabiraterone is an intermediate in synthesizing 7-Ketoabiraterone Acetate (K170980), a steroidal cytochrome P 450 17a-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| | 7-Ketoabiraterone Preparation Products And Raw materials |
|